General Information of the Compound
| Compound ID |
CP0541658
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(propan-2-ylideneamino) N-[(4-butoxyphenyl)methyl]carbamate
Show/Hide
|
||||||||||||||||||
| Synonyms |
CHEMBL597131
Propan-2-one O-4-butoxybenzylcarbamoyl oxime
propan-2-one O-4-butoxybenzylcarbamoyl oxime
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H22N2O3
|
||||||||||||||||||
| Molecular Weight |
278.352
|
||||||||||||||||||
| Canonical SMILES |
CCCCOc1ccc(CNC(=O)ON=C(C)C)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H22N2O3/c1-4-5-10-19-14-8-6-13(7-9-14)11-16-15(18)20-17-12(2)3/h6-9H,4-5,10-11H2,1-3H3,(H,16,18)
Show/Hide
|
||||||||||||||||||
| InChIKey |
VRTSWQPAWLHCJK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Propan-2-one O-4-butoxybenzylcarbamoyl oxime )
| Drug Name | Propan-2-one O-4-butoxybenzylcarbamoyl oxime | ||
|---|---|---|---|